Greensboro, NC (Oct. 16, 2008) – Novartis Animal Health US, Inc. sponsored an interactive quiz at the recent 2008 American Association of Bovine Practitioners (AABP) Annual Convention. This activity resulted in donations of $2,470 to the AABP Amstutz Scholarship Fund and $500 to the Michigan State University College of Veterinary Medicine’s student AABP Chapter.
The quiz was designed to allow veterinarians and veterinary students to test their knowledge about bovine viral diarrhea, L. hardjo-bovis, infectious bovine rhinotracheitis and scours prevention. It included questions about Novartis products Vira Shield® 6+VL5HB and Scour Bos® 9.
For each person completing the quiz, Novartis donated $10 to the AABP Amstutz Scholarship Fund, which is designed to attract well-trained veterinarians to enter food animal practice. A total of $2,470 was raised.
In addition, Novartis offered the veterinary college with the most students participating in the quiz the chance to win a $500 donation to their student AABP chapter. Nearly 20 colleges participated. Michigan State University College of Veterinary Medicine took top honors.
About Novartis Animal Health
Novartis Animal Health researches, develops and commercializes leading animal treatments that meet the needs of pet owners, farmers and veterinarians. Headquartered in Basel, Switzerland, Novartis Animal Health conducts business in 40 countries and employs about 2,700 people worldwide. For more information, please consult www.ah.novartis.us.
Novartis AG provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group’s continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 98,000 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.